Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,098,187 | -453,816 | -1,131,301 | -766,409 | -461,203 |
| Depreciation Amortization | 1,479 | 1,312 | -11,273 | -11,421 | -10,042 |
| Accounts payable and accrued liabilities | 21,888 | 16,857 | 9,535 | 20,036 | 491 |
| Other Working Capital | -1,870 | -16,945 | 86,823 | 54,577 | -1,866 |
| Other Operating Activity | 335,206 | 98,427 | 148,475 | 79,714 | 56,428 |
| Operating Cash Flow | $-741,484 | $-354,165 | $-897,741 | $-623,503 | $-416,192 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,482,231 | 174,153 | 134,048 | 57,241 | 29,043 |
| PPE Investments | -3,824 | -1,538 | -15,990 | -14,065 | -10,716 |
| Investing Cash Flow | $-1,486,055 | $172,615 | $118,058 | $43,176 | $18,327 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 732,068 | N/A | 244,215 | 244,215 | 250,000 |
| Common Stock Issued | 1,927,904 | 238,996 | 377,089 | 11,621 | 7,473 |
| Other Financing Activity | -743 | -252 | 220 | 29 | -16 |
| Financing Cash Flow | $2,659,229 | $238,744 | $621,524 | $255,865 | $257,457 |
| Beginning Cash Position | 388,603 | 388,603 | 546,762 | 546,762 | 546,762 |
| End Cash Position | 820,293 | 445,797 | 388,603 | 222,300 | 406,354 |
| Net Cash Flow | $431,690 | $57,194 | $-158,159 | $-324,462 | $-140,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -741,484 | -354,165 | -897,741 | -623,503 | -416,192 |
| Capital Expenditure | -3,824 | -1,538 | -15,990 | -14,065 | -10,716 |
| Free Cash Flow | -745,308 | -355,703 | -913,731 | -637,568 | -426,908 |